3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
40
Triple Negative Breast Neoplasms
16
Carcinoma, Transitional Cell
14
Breast Neoplasms
14
Small Cell Lung Carcinoma
12
Urinary Bladder Neoplasms
11
Melanoma
10
Carcinoma, Hepatocellular
9
Neoplasms
8
Carcinoma, Renal Cell
8
Uterine Cervical Neoplasms
6
Neoplasm Metastasis
6
Lung Neoplasms
6
Colorectal Neoplasms
5
Ovarian Neoplasms
4
Lymphoma, Follicular
4
Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Prostatic Neoplasms
3
Leukemia, Myeloid, Acute
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Stomach Neoplasms
2
Solid Tumors
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Kidney Neoplasms
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Interventions
Gemcitabine
6
Irinotecan
4
130-nm albumin-bound paclitaxel
4
Cisplatin
3
Albumin-Bound Paclitaxel
3
napabucasin
2
Leucovorin
2
Imatinib Mesylate
2
Everolimus
2
Ascorbic Acid
2
spartalizumab
1
pralsetinib
1
pembrolizumab
1
dostarlimab
1
copanlisib
1
alectinib
1
Ramucirumab
1
Paclitaxel
1
NUC-1031
1
Levoleucovorin
1
KRN-330
1
HhAntag691
1
Fluorouracil
1
Cyclophosphamide
1
Capecitabine
1
Bevacizumab
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Digestive System Neoplasms
×
atezolizumab
×
Clear all
No trials found.